$53.39
▲ +0.3% Today
as of Sep 4, 16:53 ET
Last 30 days
Recent Press Releases & News
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pulse Biosciences (PLSE) Stock Looks Pricey On Book Value Yet Strong On Returns
Overview
52-week range
$13
$55
95% of range
Avg surprise (last 2)
+4.0%
Avg reaction (last 2)
-1.4%
50% positive
Latest IV / EM
74%
EM ±11.6% · $55 · Sep 18
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 4, 2026 | Mar/2026 | $-0.27 | $-0.32 | +15.6% | -8.0% | -3.8% | earnings |
| Tue Aug 12, 2025 | Jun/2025 | $-0.28 | $-0.26 | -7.7% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $-0.25 | — | — | — | +1.0% | earnings |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $434,000 | $401,000 | — | $86,000 | $0 | $0 | — | $0 |
| Cost of revenue | $273,000 | $370,000 | — | $279,000 | $0 | $0 | — | $0 |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-25M | $-19M | — | $-20M | $-20M | $-18M | — | $-14M |
| Net income | $-25M | $-19M | — | $-19M | $-19M | $-17M | — | $-13M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $102M | $68M | $81M | $95M | $106M | $119M | $118M | $79M |
| Inventory | $236,000 | $206,000 | $136,000 | $57,000 | $51,000 | $30,000 | $0 | — |
| Total current assets | $106M | $71M | $83M | $97M | $108M | $121M | $119M | $80M |
| Total assets | $116M | $82M | $95M | $109M | $120M | $133M | $132M | $93M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $16M | $15M | $14M | $16M | $16M | $15M | $18M | $14M |
| Total equity | $100M | $66M | $81M | $93M | $104M | $118M | $115M | $79M |